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Background: Funders now frequently require that sex and gender be considered in research programmes, but
provide little guidance about how this can be accomplished, especially in large research programmes. The purpose
of this study is to present and evaluate a model for promoting sex- and gender-based analysis (SGBA) in a large
health service research programme, the Ontario Pharmacy Evidence Network (OPEN).
Methods: A mixed method study incorporating (1) team members’ critical reflection, (2) surveys (n = 37) and
interviews (n = 23) at programme midpoint, and (3) an end-of-study survey in 2016 with OPEN research project
teams (n = 6).
Results: Incorporating gender and vulnerable populations (GVP) as a cross-cutting theme, with a dedicated team
and resources to promote GVP research across the programme, was effective and well received. Team members felt
their knowledge was improved, and the programme produced several sex- and gender-related research outputs.
Not all resources were well used, however, and better communication of the purposes and roles of the team could
increase effectiveness.
Conclusions: The experience of OPEN suggests that dedicating resources for sex and gender research can be
effective in promoting SGBA research, but that research programmes should also focus on communicating the
importance of SGBA to their members.
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Over the past three decades, several important develop-
ments in health and social science literatures have af-
fected the way that differences between men and women
are addressed across fields of health research and policy.
These changes are not independent, but reflect a more
general shift toward consideration of the social as well
as the biological dimensions of these differences and* Correspondence: cooke@uwaterloo.ca
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spectives on social inequalities and differences alongside
positivist explanations. Together, these changes have led
research funders in Canada and elsewhere to require
that research teams incorporate these perspectives in
their research plans. This is the challenge that this paper
hopes to help address.
An important change that has taken place across health
and biomedical sciences has been the recognition that dif-
ferences between males and females have been systematic-
ally ignored in health research. This has included women
being under-represented in research designs, or absent en-
tirely, resulting in results being inappropriately generalisedle is distributed under the terms of the Creative Commons Attribution 4.0
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dence remains of continuing under-representation of
women in research from the United States of America
and other countries. This includes a lack of reporting of
male/female differences, despite the United States
National Institutes of Health requiring, since 1993, that
federally supported Phase III clinical trials include female
participants [2, 3].
Over the past several decades, social causes have
attracted greater attention as explanations for observed
differences between males and females for a range of
health-related outcomes and processes. Since the 1970s,
researchers have increasingly referred to the role of ‘gen-
der’, or the socially derived differences between women
and men, boys and girls, along with the physiological dif-
ferences associated with ‘sex-linked biology’ [4]. Al-
though the biological and social factors may be difficult
to conceptually and methodologically delineate, this has
led to greater attention to the importance of aspects of
culture, norms and social roles, and their implications
for a wide range of patient diagnoses, treatments and
health outcomes [5–7]. Researchers concerned with un-
derstanding gender differences in health have also called
for attention to the role of unequal social power in their
creation and maintenance. Drawing from critical femin-
ist studies, this includes consideration of how the epis-
temology and practice of health and medical research
might themselves be shaped by gender [8].
Other insights from critical social science have shaped
the study of gender and health. Developed in the 1980s
and 1990s, ‘intersectional’ approaches see social dimen-
sions of inequality, such as gender, race/ethnicity, sexual-
ity and social class, not as separate but as mutually
constitutive and interlocking, whereby the implications
of one’s positon on one dimension cannot be fully
understood without reference to others [9]. The field of
queer studies has contributed the ideas that both sexual-
ity and gender identities are fluid and multiple, rather
than fixed and binary. This has led to a new focus on
the health of transgendered people, as well as lesbian,
gay, bisexual and other sexual minorities, and of the im-
portance of including these dimensions in health re-
search and data [10, 11].
In response to the recognition of the complexities of
sex-linked biology and gender, and their critical import-
ance for health services research and policy, there have
been calls for assessments of the scientific, social and
economic benefits of research to be made specifically
with an eye to reducing gender bias [1]. To this end,
funding agencies have required researchers to incorpor-
ate both sex and gender into their research. Approaches
to considering both the social and biologically-linked di-
mensions throughout research projects are sometimes
referred to as ‘sex- and gender-based analyses’ or SGBA[12]. SGBA has been made either a requirement or a pri-
ority by public research funders [13–15]. Similar to the
National Institutes of Health [16], Health Canada imple-
mented a Sex and Gender-Based Analysis Policy in 2000
[12], and applicants to any of the Canadian Institutes of
Health Research (CIHR) funding programmes are now
expected to incorporate sex and/or gender in research
designs or to justify why they are not relevant [15, 17].
As that federal health research funding agency has put
it, “if our research designs do not take sex and gender
into account, the evidence we generate may be incom-
plete or simply incorrect; we risk not only doing harm
(such as extrapolating findings based on male samples to
females), but also missing critical opportunities to im-
prove health (for example, not detecting the benefits of
an intervention in a subgroup of men)” [18].
The proportion of CIHR-funded research projects in-
corporating sex and gender rose from 28% in 2010 to
48% in 2011, a result partly attributable to this new em-
phasis [19]. However, barriers to the integration of sex
and gender into health research projects remain. Day
et al. [20] identified a lack of consistent terminology,
challenges with applying the concepts of sex and gender
and using them to interpret results, and a lack of appro-
priate indicators on datasets as key challenges. Despite
the priority given to integrating sex and gender in health
research, there is also evidence that funding agencies
have not given a great deal of practical guidance about
how these dimensions should be integrated in research,
instead leaving researchers the freedom and responsibil-
ity for developing their own plans and models. Several
agencies and research groups have provided case studies
of SGBA approaches within specific health research and
healthcare settings [21–28]. Examples include What a
Difference Sex and Gender Make: A Gender, Sex and
Health Research Casebook [18] and Rising to the Chal-
lenge: Sex- and Gender-Based Analysis for Health Plan-
ning, Policy and Research in Canada [29]. Researchers
have also developed sex- and gender-specific tools in
order to advance research and methods in this area.
Doull et al. [30] have developed the Sex and Gender Ap-
praisal Tool to assess systematic reviews with reference
to sex and gender issues, and Briefing Notes [31] to aid
researchers to implement sex/gender analysis in system-
atic reviews. Oertelt-Prigione et al. [6] have established
GenderMedDB, an archive of medical literature contain-
ing sex- and/or gender-specific analyses.
Most of these examples focus on application of SGBA
to specific research questions, within discrete research
projects. In such projects, typically having one main
source of data and a single research team, one might ex-
pect that researchers could easily determine how sex
and gender might be important, and how to include
these dimensions in the research design. For large and
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systemic incorporation of sex and gender poses a greater
challenge. There may be multiple sub-projects, and re-
search questions and approaches might be emergent
over the course of a programme. The extant literature
provides few examples relevant to integrating a SGBA
model in these larger organisations. This paper aims to
begin to fill this gap by describing how considerations of
sex, gender and vulnerable populations (GVPs) were
promoted within a large multisite health research
programme, reporting the results of an evaluation of the
model and the lessons learned in its implementation.
Methods
The multisite research programme
The Ontario Pharmacy Evidence Network (OPEN)
(www.open-pharmacy-research.ca) is a multi-institutional
and multidisciplinary research programme established to
produce policy-relevant research in the context of changes
to medication management services in the province of
Ontario, Canada. It has received several sources of grant
support including its largest grant of CDN$5.7 million
from the Ontario Ministry of Health and Long-Term
Care’s (MOHLTC’s) Health Systems Research Fund
(2013–2016). At the time of writing, the collaboration in-
cludes over 31 investigators, 24 staff and more than 60
students from several disciplines at 10 institutions. At in-
ception, it included six main research projects, each of
which involved a number of discrete studies: Pharmacist
Services Evaluation Framework, MedsCheck and Pharma-
ceutical Opinion, Pharmacists as Immunizers, Pharmacist
Prescribing, Deprescribing Guidelines for the Elderly, and
Chronic Pain Management by Rural and Urban Commu-
nity Pharmacists. Each of these projects had an interdis-
ciplinary team (hereinafter ‘project teams’) responsible forFig. 1 OPEN organisational structuredefining their research agendas, conducting the research
and leading dissemination and knowledge translation ac-
tivities. An additional 18 research studies were initiated
through an “Applied Health Research Questions” process,
in which health system policymakers and service providers
could address specific research questions to the OPEN
teams.
Similar to other large research funding agencies,
MOHLTC requires plans for addressing sex and gender
to be included in research funding applications [32]. It
was also important to the OPEN leadership that its re-
search projects incorporate a range of other dimensions
of vulnerability (e.g. race/ethnicity, age, socioeconomic
status, dis/ability), along with sex and gender. Our goals,
conceived very broadly at the project’s outset, were (1)
to increase knowledge and awareness of both sex and
gender among OPEN research team members and (2) to
increase the integration of sex, gender and intersecting
dimensions of social inequity in OPEN research projects.
To do that, we proposed and implemented a model in
which GVPs were incorporated as a cross-cutting theme,
supported by a GVP team and dedicated resources.
The GVP team model
GVP was positioned as one of three cross-cutting
themes that supported and provided input into OPEN
research projects (the other two were Knowledge
Translation and Exchange, and Capacity Building, see
Fig. 1). These themes were given the same importance
in the OPEN organisation as the six project teams, and
were composed of researchers, administrative staff and
trainees. Like other OPEN teams, the GVP team con-
trolled their own budget, participated in OPEN activ-
ities, meetings and reporting, and conducted their own
research.
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sentative on the GVP team, and several GVP team mem-
bers were leads of their project teams. GVP members
were also selected from among OPEN members based
on their interest and previous experience with research
related to sex and gender and social inequality. The
GVP team had two co-leads; one was a non-pharmacist
social scientist with expertise in health inequities and
health research in vulnerable populations, and the other
was one of the pharmacist co-leads of the OPEN
programme, included to signal the importance of GVP
activities within the OPEN research programme and to
coordinate activities across project teams. A part-time
non-pharmacist research coordinator with graduate
training in social science research was hired to keep
track of GVP sub-projects and budgets, schedule meet-
ings, coordinate communication, and assist with re-
search and writing.
The GVP team had its own budget of approximately
CDN$50,000 per year for 2013–2016. This was intended
to pay for the salary of the part-time research coordin-
ator, to provide a small amount for administrative sup-
plies and to support additional research conducted by
the GVP team. At the outset of the research programme,
it was anticipated that the GVP team would see oppor-
tunities to augment the work of other project teams as
the research progressed; we expected this could be con-
ducting literature reviews, performing additional second-
ary analyses or collecting qualitative data to further
explore GVP themes that might be uncovered by the
projects, but which they had not planned and therefore
might not have the capacity to do themselves.
With broad goals of increasing the attention paid to
sex and gender, as well as to intersecting dimensions of
vulnerability within OPEN, the GVP team undertook ac-
tivities intended to support consideration of ‘GVP ques-
tions’ in all phases of OPEN research projects and to
build capacity by educating OPEN members about sex,
gender and vulnerable populations in medication man-
agement research. These activities included:
(1)Consulting with individual OPEN project teams,
both through formal inquiries and other more
informal interactions (e.g. conversations at meetings,
through involvement in other OPEN projects).
These were intended to assess their activities and
needs with regard to sex, gender and vulnerable
populations research, and to identify opportunities
to assist them.
(2)Developing an online module using a web-based
learning management system to provide background
information as well as resources and tools, such as a
video introducing concepts and frameworks for sex-
and gender-based analysis and intersectionality.(3)Constructing recommended survey questions to be
used by OPEN project teams collecting their own
survey data related to sex, gender, sexual orientation,
ethnicity, race, Aboriginality, and other dimensions
of identity. Consideration was given to asking
questions in a way that was inclusive, avoiding, for
example, asking respondents’ gender in a way that
requires them to choose only two options when
neither might reflect their own identity, or to
identify as ‘other’, potentially reinforcing a sense of
marginalisation. At the same time, these questions
would encourage standardised collection of these
data across OPEN research projects, and
comparability to some other national data sources.
Proposed questions were supported with a
background document that included references and
other potential questions.
(4)Adapting the MOHLTC’s Health Equity Impact
Assessment (HEIA) tool [33] to medication
management research. This tool provides a template
and workbook that help users consider the impacts
of programme or policies on health equity, directing
users to specifically consider effects on a range of
populations, including immigrants, Indigenous
peoples, age-related groups, people with disability, as
well as sex and gender. By adapting the tool for
pharmacy practice researchers, we hoped that it
would help our colleagues and others to consider
how to incorporate these dimensions in their
projects.
(5)Identifying gaps related to sex and gender in the
medication management and pharmacy practice
literature and conducting their own research to fill
these knowledge gaps.
Evaluation methods
A mixed method evaluation of the OPEN GVP activities
was conducted. Data sources included surveys and quali-
tative interviews of OPEN members 18 months after
OPEN’s launch, an OPEN member end-of-grant survey,
and GVP team meeting notes and members’ critical re-
flections [34, 35] with respect to the creation and imple-
mentation of the GVP team model. Data collection
procedures were approved by institutional research eth-
ics bodies at the University of Waterloo, McMaster
University and University of Toronto. All identifying
information was removed to ensure participant
confidentiality.
Interim OPEN member survey and interview
At the midpoint of funding in 2014, OPEN researchers,
staff and students were surveyed and interviewed in order
to understand the perceived impact of the GVP team on
knowledge among the OPEN project teams as well as their
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asked about members’ experiences and perceptions of the
operation of OPEN, including the role and effectiveness of
the GVP Team (See Additional file 1 for questionnaire
content). The survey was distributed to all current and
past OPEN team members, using Qualtrics online survey
software.
Participants in the qualitative interviews were re-
cruited using a purposive sampling method to ensure
appropriate representation of member roles and loca-
tions. To ensure respondent confidentiality, a consultant
external to OPEN conducted the interviews, using a
semi-structured questionnaire (Additional file 1). Inter-
views were conducted over the phone, using Skype or
in-person, and were audio-recorded and transcribed ver-
batim. Transcripts were analysed thematically [36] with
the use of NVivo 10 software. The analysis focused on
understanding how participants understood and engaged
with GVP team members, as well as their views of
OPEN GVP initiatives and resources. The analysis took
an inductive approach; one author coded and recoded
segments of qualitative data into higher-level and refined
themes with input from one of OPEN’s co-leads. Fifty-
three OPEN researchers, staff and students were invited
to participate. A total of 23 interviews were conducted, a
number that the interviewer and the coders felt allowed
them to achieve ‘saturation’, whereby there were no new
themes emerging from additional interviews.
End-of-study OPEN member survey
The GVP team conducted an end-of-study survey in
January and February 2016. An online questionnaire was
sent to members of each of the six project teams, asking
them to identify projects and sub-projects conducted as
part of the broader OPEN research programme. One
member from each team completed the survey. For each
sub-project, the questionnaire asked whether and how
sex and gender had been incorporated, and whether and
how the project team had made use of the resources cre-
ated by the GVP team. The survey was administered
using Qualtrics survey software. Survey responses were
tabulated using descriptive statistics.
Meeting notes and critical reflection
Starting in June 2013, members of the GVP team met bi-
weekly, either in person or by teleconference. These meet-
ings involved discussions about how the GVP team could
best serve the project teams, how to communicate with
them and what GVP activities would be most beneficial.
Notes taken during these meetings were reviewed and key
themes were identified and incorporated throughout this
paper. Two critical reflection sessions with the GVP team
co-leads and one session with the entire GVP team were
held. These sessions focused on recounting experiences ofdeveloping, implementing and evaluating the model. Notes
were recorded by one member of the GVP team and circu-
lated to the group for comment, elaboration or revision.
Results
Midpoint OPEN member survey and interview
At the midpoint of the project, the GVP team had
reached out to other project teams, both individually
and at programme meetings, about the team’s availability
to consult on GVP-related research. The online module
and other resources had been made available and were
promoted using the OPEN monthly newsletter.
Thirty-seven OPEN researchers, staff and students out
of 85 eligible past and present OPEN members com-
pleted the midpoint survey (44% response rate). The sur-
vey included questions about which dimensions of
gender or vulnerability were included in the research
projects at the time and provide a snapshot of the GVP-
related activities at midpoint, and the use of the GVP re-
sources. Most respondents (90%) indicated that sex, gen-
der or vulnerable groups were being considered within
their projects’ research. These dimensions included bio-
logical sex (72%); elderly or youth (70%); gender (57%);
rural/remote populations (41%); low-income people
(38%); inner-urban populations (30%); immigrants (27%);
ethno-racial minorities (19%); those with limited liter-
acy/health literacy (19%); people with disabilities (14%);
non-English linguistic communities (11%); sexual minor-
ities (11%); gender diverse people (11%); Indigenous peo-
ples (5%); and religious/faith communities (3%).
Respondents were asked to assess their own know-
ledge about sex, gender and vulnerable population re-
search, thinking back to the beginning of the OPEN
research programme and at the time of the survey (mid-
point); 30% reported that they had ‘little’ knowledge and
5% reported that they had ‘high’ levels of GVP know-
ledge at the beginning of the project. By comparison,
14% reported that they had ‘little’ knowledge and 48%
reported that they had ‘high’ levels of knowledge after
their involvement in OPEN.
The uptake of GVP materials and supports varied
across project teams. Almost half (46%) of respondents
said that their teams had used the recommended survey
questions; 19% had used the GVP suggested survey
question rationale and background materials; 14% had
individual consultations with the GVP team; 14% re-
ported that they had considered GVP issues independ-
ently of the GVP team; and 11% had used the GVP sex-
and gender-based analysis learning module. The main
users of services were project leads (43%), followed by
students (20%), collaborator/communication personnel
(16%) and staff (11%).
When asked about their perceptions of the GVP team
activities, 47% of survey respondents were satisfied with
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asked about how the GVP team resources and support
could be improved, respondents reported the GVP team
could provide more educational and background mate-
rials (32%), research design support (25%), data analysis
support (19%), and individual consultations (8%).
The interview respondents commented on how the
GVP team helped raise awareness around vulnerable
populations and sex and gender differences, introduced
OPEN members to new literature and the importance of
inclusive survey design. These issues had previously been
‘not on the radar’ of some respondents. As one project
team lead noted, “this exposure through OPEN opened
up my eyes to a whole area of research I didn’t know
existed, and I wouldn’t have had that opportunity if it
had not been for the GVP team.” Among students, this
educational opportunity was valued as relatively rare, as
the consideration of vulnerable populations in research
was not part of the pharmacy curriculum. Respondents
appreciated how the GVP team activities ‘surfaced’ do-
mains traditionally neglected in the field but important
to ensuring quality medication management practice.
Midpoint reflection and action
At the mid-period of the OPEN programme, the GVP
team reflected on the survey and interview results and
felt that, while respondents recognised the value of hav-
ing representatives from the GVP team working ‘along-
side’ them on their research teams, there was lack of
clarity about the role of the GVP team. OPEN members
also expressed uncertainty around which of the several
dimensions of vulnerability mentioned in the GVP
team’s materials were most important to consider in
their research.
In response, the GVP team undertook several ac-
tivities to clarify its role, activities and availability for
consultation. This included re-stating the offer of as-
sistance to project teams through the OPEN newslet-
ter and in-person meetings with project teams. A list
identifying dimensions of vulnerability that were ‘pri-
orities’ for the project was created and circulated to
the project teams. These were identified by drawing
on various sources including the stated requirements
of the Health Systems Research Fund, the mandate
letters from the Premier to provincial ministers out-
lining priority areas for their departments, a scoping
review on health disparity research in pharmacy
practice conducted by members of the GVP team
[37], and feedback from the OPEN Knowledge User
and Scientific Advisory Committees. Priority dimen-
sions included sex-linked biology, gender and gender
identity, sexual orientation, age-related groups, rural
communities, people with low income, newcomers to
Canada, ethnic and racialised minorities, Indigenouspeoples, people with mental illness, people with drug
addictions, people with disabilities, linguistic com-
munities, and people with limited literacy.
Through GVP team meeting discussions, interactions
with the project teams and in searching for SGBA training
material, it was apparent that little attention appeared to
have been paid to SGBA in medication management or
pharmacy practice research or research organisations. As
a result, several research questions became important to
the GVP team. In addition to conducting a scoping review
of health inequalities in pharmacy research [37], the team
initiated scoping reviews to understand how sex and gen-
der had previously been incorporated in pharmacy prac-
tice research [38], and to examine the state of the
literature regarding pharmacy services and Indigenous
populations, as Aboriginality is an important dimension of
health inequity in Ontario and Canada. Members of the
GVP team also obtained seed funding for a separate pro-
ject to examine geo-spatial patterns of community phar-
macies and pharmacy services in relation to vulnerable
populations.
End-of-study OPEN member survey
The 2016 end-of-project survey of OPEN teams collected
data on how the OPEN teams had used GVP resources, as
well as how sex, gender and vulnerable populations had
been included in their research activities; six out of six
teams responded (100% response rate).
All six OPEN project teams reported using the GVP
team’s recommended survey questions in their research.
Four project teams had used the online sex, gender and
intersectionality learning module. Two project teams re-
ported using individual consultations with the GVP
team, however, other project teams reported that arran-
ging formal consultations with the GVP team was not
necessary as they had a team member who was part of
the GVP team and able to provide the necessary sup-
port. None of the OPEN teams mentioned using the
modified HEIA tool in their research.
Discussion
OPEN’s GVP model is one example of how sex and gen-
der can be incorporated as a theme across a large re-
search programme. The GVP model changed over the
course of the OPEN research programme, in response to
improved understanding about the work of the project
teams and how best to promote the inclusion of dimen-
sions of vulnerability in medication management re-
search. There were some lessons learned throughout the
process.
In the initial stages of the research, some of the OPEN
project teams were unsure what questions to ask the
GVP team or how to use GVP support. At the same
time, the GVP team struggled with how to engage the
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busy, yet strategic, time early in the grant funding
period. Part of this was due to a desire of the GVP team
members to not be seen as pushing a sex and gender re-
search agenda on the other project teams, members of
which were well-respected leaders in pharmacy practice
research with well-developed research goals. In retro-
spect, the GVP team could have been somewhat more
active in communicating with the other teams. Over
time, a balance developed whereby the GVP team posi-
tioned itself as available and supportive, but also found
it effective to ‘jump start’ conversations, and proactively
offer advice and examples. In particular, engaging in our
own GVP-focused research provided the other project
teams with examples of the kinds of approaches they
could take or research questions they could ask within
their own work. In the end, the members of the other
teams were more receptive to social science perspectives
than we perhaps had given them credit for. We learned
that there was wider recognition of the importance of
these dimensions than we had anticipated.
It was also clear that we might have given more careful
thought to what, exactly, ‘vulnerability’ might mean in
the context of pharmacy practice research. Again, our
original intention was to not be prescriptive, but to try
to support our colleagues in conducting research on
whatever social dimensions they might find to be im-
portant. The use of the HEIA tool led to the GVP team
considering a range of ‘vulnerable’ populations, without
providing a general definition of vulnerability that would
help OPEN teams consider which of these dimensions
might be important for their research. The request from
the OPEN community at project midpoint for a concrete
list of vulnerabilities for the project to focus on was a
signal that more specificity was required. We tried to be
more systematic in our identification of vulnerable pop-
ulations in our response but failed to provide much bet-
ter guidance. Having a better definition of vulnerability
in the context of pharmacy practice research and a
shorter list of priority populations might have given us a
better opportunity to provide specific resources related
to those dimensions, and to help our colleagues think
through how these dimensions might intersect with sex
and gender in relation to their research topics.
We also learned the value of providing a budget dedi-
cated to these activities. Having funds set aside for the
GVP team was extremely useful and allowed the team to
pursue its own focused research projects. At the outset,
we were unsure where these funds would be needed the
most and expected that some would be spent augment-
ing the research of other OPEN projects. In the end, the
OPEN project teams already had full research agendas.
They were not in a position to take advantage of these
financial resources to pursue additional GVP-relatedquestions. These resources were more productively used
for GVP research that was led by the GVP team mem-
bers and was independent of the other research projects.
Of course, there are limitations to this study. OPEN is
composed of a particular team of researchers and,
among them, those who agreed to participate in the sur-
vey and/or interview might be different from those who
did not. The participants involved in this study may
therefore not be representative of the larger population
of pharmacy practice and health researchers. For ex-
ample, the OPEN team might have been more receptive
to considering issues related to sex, gender and vulner-
able populations in their research than were other re-
searchers, as they chose to join a group that made these
issues an important theme. The results are illustrative of
our experience within a particular setting, but may hold
lessons that are applicable to others.
The OPEN research teams will be writing manuscripts
based on their OPEN work for some time. Although we
do not know what research would have been done by
the programme in the absence of a GVP team, we are
hopeful that many of these will include more thorough
considerations of sex and gender and intersecting di-
mensions of vulnerability than would otherwise be the
case. Follow-up over the next couple of years will be tell-
ing and provide further insight into the effectiveness of
the GVP team.
Considerable interest has been generated in the issues
of sex, gender and dimensions of vulnerability from
within and beyond OPEN. Invitations to speak on topics
related to what we have called ‘GVP’ have been received
from the pharmacy practice community. In response to
presentations, colleagues have expressed a commitment
to conducting inclusive research and have indicated that
they found resources, such as the inclusive survey ques-
tions, to be helpful. Similarly, our publications in this
area have received positive social media commentary.
We take this as evidence that the need for education
and tools to support the integration of sex, gender and
intersecting dimensions in research extends beyond the
OPEN research community.
Conclusion
Integrating considerations of sex, gender and intersect-
ing dimensions of vulnerability into health research re-
mains challenging, with barriers related to a lack of
familiarity with some key concepts and a lack of tools to
facilitate data collection and analysis [20]. The experi-
ence of OPEN suggests that an interdisciplinary cross-
project structure can be a useful approach in the context
of a large and complex research programme with several
sub-projects and number of research priorities. We hope
that our description of the model, and our successes and
shortcomings, will help to inform the activities of other
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and gender in their research. We also encourage other
researchers to share their own experiences, tools and ap-
proaches, in order to further develop ‘best practices’ for
doing this work within large and multi-centre research
programmes.Additional file
Additional file 1: Appendix. Interim OPEN Member Survey and
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